Zeteo Biomedical
  • Home
  • Routes of Delivery
    • Ophthalmic
    • Nasal/ Intranasal
    • Nose to Brain
    • Sublingual
    • Animal Care
  • Biosecurity
  • Services
    • Pre-Commercial
    • Commercial
  • Technology
    • Technology Platforms
    • Delivery Devices
    • Primary Containers
  • Resources
    • In the News
    • Partners
Select Page
Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID 19 Vaccine Under Fast Track CARES Act Funded Program

Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID 19 Vaccine Under Fast Track CARES Act Funded Program

by Zeteo Biomedical | Nov 17, 2020 | Press Release

A nasal vaccine that can be self-administered is crucial to protect global populations against pandemic virus threats AUSTIN, TX – 17 November 2020 –(send2press)– Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the...

Zeteo Biomedical Introduces ZEOx1 AquilaMD™ Ophthalmic Drug Delivery System

by Zeteo Biomedical | Jun 1, 2020 | Press Release

Zeteo’s patient-centric ophthalmic delivery systems are designed for precise, self-administration of preservative free drugs and biopharmaceuticals AUSTIN, TX – 01 June 2020 — (PR.com) – Zeteo Biomedical LLC announced today the availability of the ZEOx1...

Zeteo Biomedical receives NIH Award to develop a universal nasal flu vaccine in collaboration with the Iowa State University Nanovaccine Institute

by Zeteo Biomedical | May 20, 2020 | Press Release

Vaccines that can be quickly manufactured, deployed and self-administered at global scale volumes is crucial to protect global populations against pandemic virus threats AUSTIN, TX – 20 May 2020 –(pr.com)– Zeteo Biomedical LLC, Inc., a privately held, medical...

Zeteo Biomedical Introduces ZEOx1 Orion™ Nasal Vaccine and Drug Delivery Systems

by Zeteo Biomedical | May 14, 2020 | Press Release

Zeteo’s patient-centric delivery systems are designed for quick manufacturing to facilitate rapid deployment of drugs and vaccines to global populations AUSTIN, TX – 14 May 2020 –(PR.com) – Zeteo Biomedical LLC announced today the availability of ZEOx1 Orion™...

Zeteo Biomedical LLC

PO Box 342216
Austin, Texas 78734 USA

Company Info

  • About us
  • Contact Us

Legal

  • PO Terms
  • Privacy Statement
  • Cookie policy (EU)
  • FCOI Policy

Zeteo logo
© Copyright 2020
Zeteo Biomedical LLC
All rights reserved